2019
DOI: 10.3390/ijms20194749
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models

Abstract: Coronary heart diseases are of high relevance for health care systems in developed countries regarding patient numbers and costs. Disappointingly, the enormous effort put into the development of innovative therapies and the high numbers of clinical studies conducted are counteracted by the low numbers of therapies that become clinically effective. Evidently, pre-clinical research in its present form does not appear informative of the performance of treatments in the clinic and, even more relevant, it appears t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 156 publications
0
16
0
Order By: Relevance
“…Finally, the size of the heart and coronary arteries makes them adequately suited to study atherosclerosis. Indeed, thrombus formation, plaque ruptures, IR injury and the fact that atherosclerosis develops in older pigs, provides a comparable platform to study the human disease and test therapeutic interventions that can be used in the clinic [ 10 , 167 , 185 ].…”
Section: Other Animal Modelsmentioning
confidence: 99%
“…Finally, the size of the heart and coronary arteries makes them adequately suited to study atherosclerosis. Indeed, thrombus formation, plaque ruptures, IR injury and the fact that atherosclerosis develops in older pigs, provides a comparable platform to study the human disease and test therapeutic interventions that can be used in the clinic [ 10 , 167 , 185 ].…”
Section: Other Animal Modelsmentioning
confidence: 99%
“…Despite the clinical importance of I/R injury, bedside treatments that inhibit I/R are still limited, mainly due to the complex mechanisms that contribute to I/R. New pharmacological or molecular interventions that alleviate reperfusion injury are highly desirable for current reperfusion therapy ( Baehr et al, 2019 ; Yu et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Efforts to target the oxidative insult that occurs immediately following IR using therapies such as antioxidants have proven unsuccessful (Baehr et al, 2019). The current study provides novel data demonstrating that navitoclax mediates elimination of the senescence that occurs downstream of oxidative stress and that this reduces scar size, increases angiogenesis, and improves cardiac function.…”
Section: Discussionmentioning
confidence: 99%